SIREN : 849081328
GENHEALTH CORPORATION is a French company founded 7 years ago, specialized in the sector Gestion de fonds. Based in JOUY-AUX-ARCHES (57130), this company of category PME shows in 2024 a revenue of 857 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 857 149 € | 630 477 € | 252 099 € | N/C |
| Net income | 292 820 € | 123 001 € | 68 942 € | -168 232 € |
| EBITDA | 326 950 € | 70 398 € | 16 560 € | -153 938 € |
| Net margin | 34.2% | 19.5% | 27.3% | N/C |
In 2024, GENHEALTH CORPORATION achieves revenue of 857 k€. Over the period 2021-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +50.4%. Vs 2023, growth of +36% (630 k€ -> 857 k€). After deducting consumption (73 k€), gross margin stands at 784 k€, i.e. a rate of 91%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 327 k€, representing 38.1% of revenue. Positive scissor effect: EBITDA margin improves by +27.0 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 293 k€, i.e. 34.2% of revenue. This profit can be retained or distributed to shareholders.
857 149 €
784 048 €
326 950 €
211 797 €
292 820 €
38.1%
The debt ratio (= Financial debt / Equity x 100) stands at 41%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 68%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 2.3 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 47.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
41.241%
67.594%
47.206%
2.33
83.9%
In 2024, the debt ratio of GENHEALTH CORPORATION (41.24) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of GENHEALTH CORPORATION (67.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of GENHEALTH CORPORATION (2.33) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 1355.16. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 9.6x. Operating income very largely covers interest expenses: high safety margin.
1355.162
9.56
In 2024, the liquidity ratio of GENHEALTH CORPORATION (1355.16) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of GENHEALTH CORPORATION (9.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 173 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 41 days. The gap of 132 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 170 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 432 days of revenue, i.e. 1.0 M€ to permanently finance.
1 028 579 €
173 j
41 j
170 j
432 j
Based on 62 transactions of similar company sales
in 2024,
the value of GENHEALTH CORPORATION is estimated at
1 295 450 €
(range 407 339€ - 2 841 115€).
With an EBITDA of 326 950€, the sector multiple of 4.8x is applied.
The price/revenue ratio is 0.30x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 62 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare GENHEALTH CORPORATION with other companies in the same sector:
The revenue of GENHEALTH CORPORATION in 2024 is 857 k€.
Yes, GENHEALTH CORPORATION generated a net profit of 293 k€ in 2024.
The headquarters of GENHEALTH CORPORATION is located in JOUY-AUX-ARCHES (57130), in the department Moselle.
The tax return of GENHEALTH CORPORATION is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
GENHEALTH CORPORATION operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.